Involvement of MAPSs in ICAM-1 expression in glomerular endothelial cells in diabetic nephropathy

Acta Medica Okayama

Volumn 65, Issue 4, 2011, Pages 247-257

  Watanabe, Naomi ^a   Shikata, Kenichi ^a,b   Shikata, Yasushi ^a   Sarai, Kei ^a   Omori, Kazuyoshi ^a   Kodera, Ryo ^a   Sato, Chikage ^a   Wada, Jun ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Diabetic nephropathy; ERK; ICAM 1; JNK; P 38 MAPK

Indexed keywords

RATTUS;

GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; DIABETIC NEPHROPATHY; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS; HUMAN; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GLUCOSE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY GLOMERULUS; MALE; MANNITOL; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80052681811     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hiragushi K, Sugimoto H, Shikata K, Yamashita T, Miyatake N, Shikata Y, Wada J, Kumagai I, Fukushima M and Makino H: Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes. Diabetes Res Clin Pract (2001)53: 149-159.
2. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE and Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A (1994) 91: 9436-9440.
3. Dunlop M: Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl (2000) 77: S3-12.
4. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K and King GL: Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest (1997) 100: 115-126.
5. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 414: 813-820.
6. Sharma K and Ziyadeh FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes (1995) 44: 1139-1146.
7. Furuta T, Saito T, Ootaka T, Soma J, Obara K, Abe K and Yoshinaga K: The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis (1993) 21: 480-485.
8. Sassy-Prigent C, Heudes D, Mandet C, Belair MF, Michel O, Perdereau B, Bariety J and Bruneval P: Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes (2000) 49: 466-475.
9. ChowF, Ozols E, Nikolic-Paterson DJ, Atkins RC and Tesch GH: Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int (2004) 65: 116-128.
10. Sugimoto H, Shikata K, Hirata K, Akiyama K, Matsuda M, Kushiro M, Shikata Y, Miyatake M and Makino H: Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes (1997) 46: 2075-2081.
11. Hirata K, Shikata K, Matsuda M, Akiyama K, Sugimoto H, Kushiro M and Makino H: Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia (1998) 41: 185-192.
12. Shikata K, Makino H: Role of macrophages in the pathogenesis of diabetic nephropathy. Contrib Nephrol (2001) 134: 46-54.
13. Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, Wada J, Shikata Y and Makino H: Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes (2003) 52: 2586-2593.
14. Usui H, Shikata K, Matsuda M, Okada S, Ogawa D, Yamashita T, Hida K, Satoh M, Wada J and Makino H: HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant (2003) 18: 265-272.
15. Tone A, Shikata K, Sasaki M, Ohga S, Yozai K, Nishishita S, Usui H, Nagase R, Ogawa D, Okada S, Shikata Y, Wada J and Makino H: Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats. Diabetologia (2005) 48: 2402-2411.
16. Yozai K, Shikata K, Sasaki M, Tone A, OhgaS, Usui H, Okada S, Wada J, Nagase R, Ogawa D, Shikata Y and Makino H: Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions. J Am Soc Nephrol (2005) 16: 3326-3338.
17. Ohga S, Shikata K, Yozai K, Okada S, Ogawa D, Usui H, Wada J and Makino H: Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. Am J Physiol Renal Physiol (2007)292: F1141-1150.
18. Altannavch TS, Roubalova K, Kucera P and Andel M: Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol Res (2004) 53: 77-82.
19. Park CW, Kim JH, Lee JH, Kim YS, Ahn HJ, Shin YS, Kim SY, Choi EJ, Chang YS and Bang BK: High glucose-induced intercel lular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent. Diabetologia (2000) 43: 1544-1553.
20. Shikata Y, Birukov KG, Birukova AA, Verin A and Garcia JG: Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT. Faseb J (2003) 17: 2240-2249.
21. Shikata Y, Birukov KG and Garcia JG: S1P induces FA remodeling in human pulmonary endothelial cells: role of Rac, GIT1, FAK, and paxillin. J Appl Physiol (2003) 94: 1193-1203.
22. Wertheimer SJ, Myers CL, Wallace RW and Parks TP: Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate. J Biol Chem (1992) 267: 12030-12035.
23. Lane TA, Lamkin GE and Wancewicz E: Modulation of endothelial cell expression of intercellular adhesion molecule 1 by protein kinase C activation. Biochem Biophys Res Commun (1989) 161: 945-952.
24. Vlassara H, Fuh H, Donnelly T and Cybulsky M: Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med (1995) 1: 447-456.
25. Sengoelge G, Fodinger M, Skoupy S, Ferrara I, Zangerle C, Rogy M, Höri WH, Sundev-plassmann G and Menzel J.: Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin. Kidney Int (1998) 54: 1637-1651.
26. Nagel T, Resnick N, Atkinson WJ, Dewey CF Jr and Gimbrone MA, Jr.: Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest (1994) 94: 885-891.
27. Lo SK, Janakidevi K, Lai L and Malik AB: Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am J Physiol (1993) 264: L406-412.
28. Taki H, Kashiwagi A, Tanaka Y and Horiike K: Expression of intercellular adhesion molecules 1 (ICAM-1) via an osmotic effect in human umbilical vein endothelial cells exposed to high glucose medium. Life Sci (1996) 58: 1713-1721.
29. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ and King GL: Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest (1999) 103: 185-195.
30. Kang MJ, Wu X, Ly H, Thai K and Scholey JW: Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli. Kidney Int (1999) 55: 2203-2214.
31. Duzgun SA, Rasque H, Kito H, Azuma N, Li W, Basson MD, Gahtan V, Dudrick SJ and Sumpio BE: Mitogen-activated protein phosphorylation in endothelial cells exposed to hyperosmolar conditions. J Cell Biochem (2000) 76: 567-571.
32. Liu W, Schoenkerman A and Lowe WL Jr: Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am J Physiol Endocrinol Metab (2000) 279: E782-790.
33. Ho FM, Liu SH, Liau CS, Huang PJ and Lin-Shiau SY: High glu cose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH (2)-terminal kinase and cas-pase-3. Circulation (2000) 101: 2618-2624.
34. Busik JV, Mohr S and Grant MB: Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on para-crine mediators. Diabetes (2008) 57: 1952-1965.
35. Adhikary L, Chow F, Nikolic-Paterson DJ, Stambe C, Dowling J, Atkins RC and Tesch GH: Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia (2004) 47: 1210-1222.
36. Sakai N, Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K, Kokubo S, Kobayashi M, Hara A, Yamahana J, Okumura T, Takasawa K, Takeda S, Yoshimura M, Kida H and Yokoyama H: Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis (2005) 45: 54-65.
37. De Borst MH, Prakash J, Melenhorst WB, van den Heuvel MC, Kok RJ, Navis G and Van Goor H: Glomerular and tubular induction of the transcription factor c-Jun in human renal disease. J Pathol (2007) 213: 219-228.
38. Berl T, Siriwardana G, Ao L, Butterfield LM and Heasley LE: Multiple mitogen-activated protein kinases are regulated by hyper-osmolality in mouse IMCD cells. Am J Physiol (1997) 272: F305-311.
39. Malek AM, Goss GG, Jiang L, Izumo S and Alper SL: Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. Stroke (1998) 29: 2631-2640.
40. Kayali AG, Austin DA and Webster NJ: Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes. Diabetes (2000) 49: 1783-1793.
41. McGinn S, Saad S, Poronnik P and Pollock CA: High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase. Am J Physiol Endocrinol Metab (2003) 285: E708-717.
42. Farkas A, Szatmari E, Orbok A, Wilhelm I, Wejksza K, Nagyoszi P, Hutamekalin P, Bauer H, Traweger A and Krizbai A: Hyperosmotic mannitol induces Src kinase-dependent phosphorylation of beta-catenin in cerebral endothelial cells. J Neurosci Res (2005) 80: 855-861.
43. Kuldo JM, Westra J, Asgeirsdottir SA, Kok RJ, Oosterhuis K, Rots MG, Schouten JP, Limburg PC and Molema G: Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{α}-and IL-1{β}-induced proinflammatory status of endothelial cells in vitro. Am J Physiol Cell Physiol (2005) 289: C1229-1239.
44. Nizamutdinova IT, Oh HM, Min YN, Park SH, Lee MJ, Kim JS, Yean MH, Kang SS, Kim YS, Chang KC and Kim HJ: Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways. Int Immunopharmacol (2007) 7: 343-350.
45. Zheng HT, Zhou LN, Huang CJ, Hua X, Jian R, Su BH and Fang F: Selenium inhibits high glucose- and high insulin-induced adhesion molecule expression in vascular endothelial cells. Arch Med Res (2008) 39: 373-379.
46. Riad A, Unger D, Du J, Westermann D, Mohr Z, Sobirey M, Dorenkamp M, Schultheiss HP and Tschöpe C: Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus. Eur J Pharmacol (2007) 554: 40-45.